Structural and functional insights on the roles of molecular chaperones in the mistargeting and aggregation phenotypes associated with primary hyperoxaluria type I-Reference-Cited by-同舟云学术

Structural and functional insights on the roles of molecular chaperones in the mistargeting and aggregation phenotypes associated with primary hyperoxaluria type I

Published:2019 Issue: Volume: Page:119-152
ISSN:1876-1623
Container-title:Molecular Chaperones in Human Disorders
language:
Short-container-title:

Author:

Fernández-Higuero José Ángel,Betancor-Fernández Isabel,Mesa-Torres Noel,Muga Arturo,Salido Eduardo,Pey Angel L.

Publisher

Elsevier

Reference140 articles.

1. Chaperone-assisted protein aggregate reactivation: Different solutions for the same problem;Aguado;Archives of Biochemistry and Biophysics,2015

2. Structure of GroEL in complex with an early folding intermediate of alanine glyoxylate aminotransferase;Albert;The Journal of Biological Chemistry,2010

3. Crystal structure of an Hsp90-nucleotide-p23/Sba1 closed chaperone complex;Ali;Nature,2006

4. Structural characterization of the substrate transfer mechanism in Hsp70/Hsp90 folding machinery mediated by hop;Alvira;Nature Communications,2014

5. Adapting proteostasis for disease intervention;Balch;Science (New York, N.Y.),2008

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Insights into the pathogenesis of primary hyperoxaluria type I from the structural dynamics of alanine:glyoxylate aminotransferase variants;FEBS Letters;2024-01-19

2. Metabolic Heterogeneity, Plasticity, and Adaptation to “Glutamine Addiction” in Cancer Cells: The Role of Glutaminase and the GTωA [Glutamine Transaminase—ω-Amidase (Glutaminase II)] Pathway;Biology;2023-08-14

3. Molecular Mechanisms, Genotype–Phenotype Correlations and Patient-Specific Treatments in Inherited Metabolic Diseases;Journal of Personalized Medicine;2023-01-05

4. Phosphorylation of Thr9 Affects the Folding Landscape of the N-Terminal Segment of Human AGT Enhancing Protein Aggregation of Disease-Causing Mutants;Molecules;2022-12-10

5. Improving Treatment Options for Primary Hyperoxaluria;Drugs;2022-07